Evidence map›Paper›PMID 41566047›Full record

ArticleAnalytical and bioanalytical chemistry2026

Molecular networking, conformal predictions and revised fingerprint-based models for discovering endocrine disruptors in mixtures.

Yvonne Kreutzer, Ida Rahu, Ulf Norinder, Anneli Kruve

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yvonne KreutzerDepartment of Chemistry, Stockholm University, Svante Arrhenius Väg 16, 106 91, Stockholm, Sweden.
Ida RahuDepartment of Chemistry, Stockholm University, Svante Arrhenius Väg 16, 106 91, Stockholm, Sweden.
Ulf NorinderDepartment of Computer and Systems Sciences, Stockholm University, P.O.Box 1073, 164 25, Kista, Sweden.
Anneli KruveDepartment of Chemistry, Stockholm University, Svante Arrhenius Väg 16, 106 91, Stockholm, Sweden. anneli.kruve@su.se.ORCID http://orcid.org/0000-0001-9725-3351

Funding

Carl Tryggers Stiftelse för Vetenskaplig Forskning 22:2336European Research Council 101124488Vetenskapsrådet 2022-01353
6 · The paper itself

Abstract

Prioritizing high-risk features is a key step to reduce workload in non-targeted screening (NTS) when identifying environmental contaminants. Machine learning models from the MS2Tox toolbox have shown promise for feature prioritization, but rely heavily on the accuracy of molecular formulas and fingerprint features provided by SIRIUS + CSI:FingerID. In this study, we introduce and evaluate two new approaches-molecular networking (MN) and conformal predictions-to discover unidentified compounds potentially posing endocrine-disrupting activity based on tandem mass spectral similarity. Furthermore, we revised the previously published MS2Tox models, leveraging molecular fingerprints for seven Tox21 Data Challenge endpoints. The fingerprint-based MS2Tox models achieved the lowest false positive rate, 0.35, at 90% recall on the test set, while MN and CP yielded 0.82 and 0.68, respectively. In a case study of transformation products and persistent chemicals in wastewater, these three approaches prioritized 29 features in influent and effluent samples as potentially associated with AhR agonism among 189 LC/HRMS features corresponding to transformation products and persistent chemicals. All candidate structures for prioritized features showed scaffolds related to AhR binding affinity. Three features were identified on level 1, showcasing potential in using combined feature prioritization strategies.

Indexed as

Endocrine DisruptorsWater Pollutants, ChemicalMachine LearningTandem Mass SpectrometryEndocrine DisruptorsWater Pollutants, ChemicalHazardHigh-resolution mass spectrometryMachine learningToxicityUntargeted screening

Identifiers

PMID41566047
PMCPMC12909378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.